Hayter C R, Paszat L F, Groome P A, Schulze K, Mackillop W J
The Radiation Oncology Research Unit, Kingston Regional Cancer Centre, Department of Oncology, Queen's University, Kingston, Ontario, Canada.
Cancer. 2000 Jul 1;89(1):142-51.
To the authors' knowledge no previous study has described the management and outcome of bladder carcinoma on a population-based level. The objective of the current study was to describe the characteristics, treatment, and outcome of newly diagnosed invasive bladder carcinoma (n = 20,822) reported in Ontario, Canada between 1982-1994.
Electronic records of invasive bladder carcinoma (International Classification of Diseases code 188) from the Ontario Cancer Registry were linked to surgical and radiotherapy (RT) records. Bivariate and multivariate techniques were used to assess variations in the use of initial cystectomy and pelvic RT. The authors modeled the likelihood of death after diagnosis and the probability of cystectomy free survival. All analyses were controlled for age, gender, histology, and year of diagnosis.
The most common histologic type was papillary transitional cell carcinoma. Maximum initial treatment was comprised of total cystectomy (5.1%), partial cystectomy or open excision (3. 5%), pelvic RT (5.9%), transurethral resection of the bladder (66. 7%), or lesser or no procedures (18.7%). The use of total cystectomy and pelvic RT varied among the regions of Ontario. Overall 5-year survival was 58.8%, and was 86.5% for patients with papillary histology. In multivariate analysis, although survival was similar among the regions, the relative risk of cystectomy conditional on survival varied.
Papillary tumors portend a better survival than nonpapillary tumors. Variations in the use of total cystectomy and in the use of pelvic RT among the regions of Ontario did not appear to be associated with variations in survival. However, cystectomy free survival appeared to vary among the regions. These results suggest that patients can be managed safely using a bladder-preserving approach.
据作者所知,此前尚无研究在基于人群的层面描述膀胱癌的管理及转归情况。本研究的目的是描述1982年至1994年期间在加拿大安大略省报告的新诊断浸润性膀胱癌(n = 20,822)的特征、治疗及转归。
安大略癌症登记处的浸润性膀胱癌(国际疾病分类代码188)电子记录与手术及放疗记录相链接。采用双变量和多变量技术评估初次膀胱切除术和盆腔放疗使用情况的差异。作者对诊断后死亡的可能性及膀胱切除术后无瘤生存的概率进行建模。所有分析均对年龄、性别、组织学类型及诊断年份进行了校正。
最常见的组织学类型是乳头状移行细胞癌。初始治疗方式主要包括全膀胱切除术(5.1%)、部分膀胱切除术或开放性切除术(3.5%)、盆腔放疗(5.9%)、经尿道膀胱切除术(66.7%)或手术操作较少或未进行手术(18.7%)。全膀胱切除术和盆腔放疗的使用在安大略省各地区有所不同。总体5年生存率为58.8%,乳头状组织学类型的患者为86.5%。在多变量分析中,尽管各地区生存率相似,但基于生存情况的膀胱切除术相对风险有所不同。
乳头状肿瘤的生存率高于非乳头状肿瘤。安大略省各地区全膀胱切除术和盆腔放疗的使用差异似乎与生存率差异无关。然而,膀胱切除术后无瘤生存情况在各地区似乎有所不同。这些结果表明,采用保留膀胱的方法可以安全地管理患者。